Literature DB >> 11712924

Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.

J B Hrachovec, M Mora.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712924

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  32 in total

1.  Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

Authors:  Peter Jüni; Anne W S Rutjes; Paul A Dieppe
Journal:  BMJ       Date:  2002-06-01

2.  Key questions concerning paracetamol and NSAIDs for osteoarthritis.

Authors:  P Courtney; M Doherty
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

Review 3.  Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.

Authors:  Jan C Becker; Wolfram Domschke; Thorsten Pohle
Journal:  Br J Clin Pharmacol       Date:  2004-12       Impact factor: 4.335

4.  Transparency in drug regulation: mirage or oasis?

Authors:  Joel Lexchin; Barbara Mintzes
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

Review 5.  Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

Authors:  Karmela Krleza-Jerić; An-Wen Chan; Kay Dickersin; Ida Sim; Jeremy Grimshaw; Christian Gluud
Journal:  BMJ       Date:  2005-04-23

6.  Principles for evidence-based drug formulary policy.

Authors:  Gregory E Simon; Bruce M Psaty; Jennifer Berg Hrachovec; Marc Mora
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

7.  Life without COX 2 inhibitors.

Authors:  Allen F Shaughnessy; Andrea E Gordon
Journal:  BMJ       Date:  2006-06-03

8.  JAMA's policy on industry sponsored studies.

Authors:  Phil B Fontanarosa; Catherine D DeAngelis
Journal:  BMJ       Date:  2006-01-21

9.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.

Authors:  Laurence J Hirsch
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

Review 10.  Celecoxib: a review of its use in the management of arthritis and acute pain.

Authors:  James E Frampton; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.